Baird Medical Investment Holdings (BDMD) Finished Goods (2023 - 2025)
Baird Medical Investment Holdings' (BDMD) quarterly Finished Goods came in at $511000.0 in Q4 2025, down 28.76% year-on-year from $717312.0 in Q4 2024, and down 28.76% on a QoQ basis from $717312.0 in Q4 2024.
Baird Medical Investment Holdings (BDMD) Finished Goods (2023 - 2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has 3 years of Finished Goods data on file, last reported at $511000.0 in Q4 2025.
- On a quarterly basis, Finished Goods fell 28.76% year-over-year to $511000.0 in Q4 2025; TTM through Dec 2025 was $511000.0, a 28.76% decrease from a year earlier, with the FY2025 full-year figure at $511000.0, down 28.76% from the prior year.
- Finished Goods for Q4 2025 stood at $511000.0, down from $717312.0 in the prior quarter.
- Over the last five years, Finished Goods for BDMD reached as high as $717312.0 in Q4 2024 and fell as low as $312871.0 in Q4 2023.
- Historically, Finished Goods has averaged $513727.7 across 3 years, with a median of $511000.0 in 2025.
- Across the five-year window, Finished Goods surged 129.27% in 2024 and decreased 28.76% in 2025, its largest moves.
- Year by year, Finished Goods stood at $312871.0 in 2023, then jumped by 129.27% to $717312.0 in 2024, then decreased by 28.76% to $511000.0 in 2025.
- Per Business Quant data, the three most recent Finished Goods figures were $511000.0 in Q4 2025, $717312.0 in Q4 2024, and $312871.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Baird Medical Investment Holdings | 30.57 Mn | 30.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 511,000.00 |
| Dec 31, 2024 | 717,312.00 |
| Dec 31, 2023 | 312,871.00 |